Heterocyclic derivatives as modulators of ion channels

Details for Australian Patent Application No. 2008321142 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Zimmermann, Nicole; Hampton, Tara Leanne; Neubert, Timothy; Numa, Mehdi michel Djamel; Martinborough, Esther; Stamos, Dean; Whitney, Tara

Agent Baldwins

Pub. Number AU-A-2008321142

PCT Pub. Number WO2009/064752

Priority 60/987,490 13.11.07 US

Filing date 12 November 2008

Wipo publication date 22 May 2009

International Classifications

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

17 June 2010 PCT application entered the National Phase

  PCT publication WO2009/064752 Priority application(s): WO2009/064752

24 June 2010 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Vertex Pharmaceuticals Incorporated, Application No. 2008321142, under INID (72) correct the co-inventor to Numa, Mehdi Michel Djamel.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008321156-Preamble design for a wireless signal

2008321137-4(-3-(-2-(phenyl)morpholino)-2-oxopyrro lidin1-yl)-n-(thiazol-2-yl)benzenesulfonamid e derivati ves and related compounds as modulators of ion channels for the treatment of pain